Column Group LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 14, 2025), Column Group LLC reported 5 stock positions worth $44.2 million. Its top holding was Oric Pharmaceuticals (ORIC) at 44.7% of the portfolio, followed by Surrozen (SRZN, 39.5%) and Tenaya Therapeutics (TNYA, 12.1%). Compared with Q4 2024, it added to 1. The biggest buy was Surrozen (SRZN, shares +85%).
- Most Recent 13F
- Q2 2026
- Location
- San Francisco, CA
- CIK
- 0001833486
- Portfolio Value
- $44.2M (Q1 2025)
- SEC Filing
- 0000950123-25-005219 ↗ filed May 14, 2025
Holdings Value
Holdings 5 stocks · $44.2M
| ORIC Oric Pharmaceuticals Inc. | 44.67% | 3,540,777 | $19.8M | No change |
| SRZN Surrozen Inc. | 39.54% | 1,499,773 | $17.5M | Add +85.1% |
| TNYA Tenaya Therapeutics Inc. | 12.12% | 9,400,290 | $5.4M | No change |
| RAPT THERAPEUTICS INC | 3.67% | 1,328,613 | $1.6M | No change |
| RVMD Revolution Medicines Inc. | 0.00% | 46 | $2K | No change |
Portfolio Sells Q4 2024 → Q1 2025
| None this quarter. | |||
Portfolio Buys Q4 2024 → Q1 2025
| SRZN Surrozen Inc. | Add +85.1% | 39.54% | +18.69 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $88.1M | SRZN, ORIC, RVMD |
| Q1 2026 | 3 | $100.7M | SRZN, ORIC, RVMD |
| Q4 2025 | 5 | $82.8M | SRZN, ORIC, TNYA, RAPT THERAPEUTICS INC, RVMD |
| Q3 2025 | 5 | $81.0M | ORIC, SRZN, TNYA, RAPT THERAPEUTICS INC, RVMD |
| Q2 2025 | 5 | $65.7M | ORIC, SRZN, RAPT THERAPEUTICS INC, TNYA, RVMD |
| Q1 2025 | 5 | $44.2M | ORIC, SRZN, TNYA, RAPT THERAPEUTICS INC, RVMD |
| Q4 2024 | 5 | $55.7M | ORIC, TNYA, SRZN, RAPT THERAPEUTICS INC, RVMD |
| Q3 2024 | 6 | $69.6M | ORIC, TNYA, SRZN, RAPT THERAPEUTICS INC, SGMT |
| Q2 2024 | 6 | $71.3M | TNYA, ORIC, SRZN, RAPT THERAPEUTICS INC, SGMT |
| Q1 2024 | 7 | $160.5M | TNYA, ORIC, NGM, RAPT THERAPEUTICS INC, SRZN |